Company Registration No. 02981251 (England and Wales)
Wrapex Limited
Report and financial statements
for the period ended 31 December 2024
Wrapex Limited
Company information
Directors
Stanislaus Schmidt-Chiari
Joseph Barry
Jonathan Crowley
(Appointed 18 January 2024)
Company number
02981251
Registered office
Unit 6, Lodge Causeway Trading Estate
Lodge Causeway
Fishponds
Bristol
BS16 3JB
Independent auditor
Saffery LLP
St Catherine's Court
Berkeley Place
Clifton
Bristol
BS8 1BQ
Business address
Unit 6, Lodge Causeway Trading Estate
Lodge Causeway
Fishponds
Bristol
BS16 3JB
Bankers
Santander UK plc
One Glass Wharf
Avon Street
Bristol
BS2 0EL
Wrapex Limited
Contents
Page
Strategic report
1
Directors' report
2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 23
Wrapex Limited
Strategic report
For the period ended 31 December 2024
1

The directors present the strategic report for the period ended 31 December 2024.

Overview

During the 15 month period ended 31 December 2024, Wrapex Limited recognised turnover of £20.3m which compares to £18.1m for the year ended 30 September 2023. The increase is due to the change in accounting period to align with Group, however the directors are pleased with how the company has performed, given the continued volatility of raw material and global trade tensions.

 

Despite geopolitical uncertainty, our company has delivered a strong performance in 2024, driven by our focus on innovation, strategic partnerships, and adaptability.

 

The business has continued to make investments in sales & marketing to support new product development and sustainability initiatives. This includes the launch of the UK manufactured, Speedwrap dispensing system to drive long term profitable growth. UK manufacturing production remains a key differentiator from its competitors and this strategy will continue into 2025 to seek new opportunity.

On behalf of the board

Jonathan Crowley
Director
24 June 2025
Wrapex Limited
Directors' report
For the period ended 31 December 2024
2
The directors present their report and financial statements for the period ended 31 December 2024.
Principal activities

The principal activity of the company continued to be that of conversion and packing film and foil wraps for use in the catering and food service sectors.

Results and dividends

The results for the period are set out on page 7.

Ordinary dividends were paid amounting to £750,000. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the period and up to the date of signature of the financial statements were as follows:

Stewart Cantley
(Resigned 31 March 2024)
Stanislaus Schmidt-Chiari
Joseph Barry
Jonathan Crowley
(Appointed 18 January 2024)
Auditor

Saffery LLP have expressed their willingness to continue in office.

Statement of disclosure to auditor

So far as the directors at the date of approving this report are aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
Jonathan Crowley
Director
24 June 2025
Wrapex Limited
Directors' responsibilities statement
For the period ended 31 December 2024
3

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law).

 

Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Wrapex Limited
Independent auditor's report
To the members of Wrapex Limited
4
Opinion

We have audited the financial statements of Wrapex Limited (the 'company') for the period ended 31 December 2024 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Wrapex Limited
Independent auditor's report (continued)
To the members of Wrapex Limited
5

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

 

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud are detailed below.

 

Identifying and assessing risks related to irregularities:

We assessed the susceptibility of the company’s financial statements to material misstatement and how fraud might occur, including through discussions with the directors, discussions within our audit team planning meeting, updating our record of internal controls and ensuring these controls operated as intended. We evaluated possible incentives and opportunities for fraudulent manipulation of the financial statements. We identified laws and regulations that are of significance in the context of the company by discussions with directors and by updating our understanding of the sector in which the company operates.

 

Laws and regulations of direct significance in the context of the company include The Companies Act 2006 and UK Tax legislation.

Wrapex Limited
Independent auditor's report (continued)
To the members of Wrapex Limited
6

Audit response to risks identified

We considered the extent of compliance with these laws and regulations as part of our audit procedures on the related financial statement items including a review of financial statement disclosures. We reviewed the company's records of breaches of laws and regulations, minutes of meetings and correspondence with relevant authorities to identify potential material misstatements arising. We discussed the company's policies and procedures for compliance with laws and regulations with members of management responsible for compliance.

During the planning meeting with the audit team, the engagement partner drew attention to the key areas which might involve non-compliance with laws and regulations or fraud. We enquired of management whether they were aware of any instances of non-compliance with laws and regulations or knowledge of any actual, suspected or alleged fraud. We addressed the risk of fraud through management override of controls by testing the appropriateness of journal entries and identifying any significant transactions that were unusual or outside the normal course of business. We assessed whether judgements made in making accounting estimates gave rise to a possible indication of management bias. At the completion stage of the audit, the engagement partner’s review included ensuring that the team had approached their work with appropriate professional scepticism and thus the capacity to identify non-compliance with laws and regulations and fraud.

There are inherent limitations in the audit procedures described above and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Neil Davies
Senior Statutory Auditor
For and on behalf of Saffery LLP
24 June 2025
Statutory Auditors
St Catherine's Court
Berkeley Place
Clifton
Bristol
BS8 1BQ
Wrapex Limited
Statement of comprehensive income
For the period ended 31 December 2024
7
Period
Year
ended
ended
31 December
30 September
2024
2023
Notes
£
£
Turnover
3
20,298,801
18,047,325
Cost of sales
(15,377,282)
(14,590,572)
Gross profit
4,921,519
3,456,753
Distribution costs
(324,181)
(237,225)
Administrative expenses
(3,345,143)
(2,577,071)
Other operating income
810,000
648,000
Operating profit
4
2,062,195
1,290,457
Interest receivable and similar income
8
31,955
9,527
Interest payable and similar expenses
9
(21,478)
(17,051)
Profit before taxation
2,072,672
1,282,933
Tax on profit
10
(420,220)
(225,600)
Profit for the financial period
1,652,452
1,057,333
Wrapex Limited
Balance sheet
As at 31 December 2024
8
31 December 2024
30 September 2023
Notes
£
£
£
£
Fixed assets
Intangible assets
12
18,783
7,010
Tangible assets
13
1,107,301
1,027,432
1,126,084
1,034,442
Current assets
Stocks
14
2,189,478
2,505,574
Debtors
15
12,214,466
8,975,303
Cash at bank and in hand
871,287
1,353,285
15,275,231
12,834,162
Creditors: amounts falling due within one year
16
(9,075,867)
(7,347,157)
Net current assets
6,199,364
5,487,005
Total assets less current liabilities
7,325,448
6,521,447
Creditors: amounts falling due after more than one year
17
(90,872)
(208,132)
Provisions for liabilities
Deferred tax liability
19
239,120
220,311
(239,120)
(220,311)
Net assets
6,995,456
6,093,004
Capital and reserves
Called up share capital
21
101,000
101,000
Profit and loss reserves
6,894,456
5,992,004
Total equity
6,995,456
6,093,004
The financial statements were approved by the board of directors and authorised for issue on 24 June 2025 and are signed on its behalf by:
Jonathan Crowley
Director
Company Registration No. 02981251
Wrapex Limited
Statement of changes in equity
For the period ended 31 December 2024
9
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 October 2022
101,000
5,534,671
5,635,671
Year ended 30 September 2023:
Profit and total comprehensive income
-
1,057,333
1,057,333
Dividends
11
-
(600,000)
(600,000)
Balance at 30 September 2023
101,000
5,992,004
6,093,004
Period ended 31 December 2024:
Profit and total comprehensive income
-
1,652,452
1,652,452
Dividends
11
-
(750,000)
(750,000)
Balance at 31 December 2024
101,000
6,894,456
6,995,456
Wrapex Limited
Notes to the financial statements
For the period ended 31 December 2024
10
1
Accounting policies
Company information

Wrapex Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 6, Lodge Causeway Trading Estate, Lodge Causeway, Fishponds, Bristol, BS16 3JB.

1.1
Reporting period

The company extended its accounting period to 31 December 2024 to align with other group companies. The comparative amounts presented in the financial statements (including the related notes) are therefore not entirely comparable.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Prowrap Limited. These consolidated financial statements are available from Unit 6, Lodge Causeway Trading Estate, Lodge Causeway, Fishponds, Bristol, BS16 3JB.

1.3
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Turnover

Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
1
Accounting policies (continued)
11

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.5
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer software
33.33% straight line
Patents & Trademarks
33.33% straight line
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings leasehold
6.67% - 20% straight line
Plant and machinery
10% - 33.33% straight line
1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
1
Accounting policies (continued)
12
1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to net realisable value.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.9
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and deposits held at call with banks.

1.10
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
1
Accounting policies (continued)
13
Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.11
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
1
Accounting policies (continued)
14
1.12
Derivatives

Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.

 

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

1.13
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Where items recognised in other comprehensive income or equity are chargeable to or deductible for tax purposes, the resulting current or deferred tax expense or income is presented in the same component of comprehensive income or equity as the transaction or other event that resulted in the tax expense or income. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.14
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.15
Retirement benefits
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are charged to the profit and loss account in the period they are payable.
Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
1
Accounting policies (continued)
15
1.16
Share-based payments

Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black-Scholes model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

When the terms and conditions of equity-settled share-based payments at the time they were granted are subsequently modified, the fair value of the share-based payment under the original terms and conditions and under the modified terms and conditions are both determined at the date of the modification. Any excess of the modified fair value over the original fair value is recognised over the remaining vesting period in addition to the grant date fair value of the original share-based payment. The share-based payment expense is not adjusted if the modified fair value is less than the original fair value.

 

Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.

The company participates in a share-based payment arrangement granted by its parent company to its employees. The company has elected to recognise and measure its share-based payment expense on the basis of a reasonable allocation of the expense for the group. The directors consider the time spent by the employees working on behalf of each entity within the Group to be a reasonable basis for allocating the expense.

1.17
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.18
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
16
2
Critical accounting judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Turnover and other revenue

An analysis of the company's turnover is as follows:

2024
2023
£
£
Turnover analysed by class of business
Sale of goods
20,298,801
18,047,325
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
18,935,388
16,278,416
Europe
1,360,476
1,763,922
Rest of the World
2,937
4,987
20,298,801
18,047,325
2024
2023
£
£
Other significant revenue
Interest income
31,955
9,527
4
Operating profit
2024
2023
Operating profit for the period is stated after charging:
£
£
Exchange losses
54,878
57,140
Depreciation of owned tangible fixed assets
273,400
168,004
Depreciation of tangible fixed assets held under finance leases
118,426
82,072
Amortisation of intangible assets
9,975
6,505
Operating lease charges
247,007
208,498
Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
17
5
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
8,600
8,500
For other services
Taxation compliance services
2,500
2,400
All other non-audit services
1,250
1,100
3,750
3,500
6
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2024
2023
Number
Number
42
44

Their aggregate remuneration comprised:

2024
2023
£
£
Wages and salaries
2,188,287
1,788,205
Pension costs
56,672
76,813
2,244,959
1,865,018
7
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
398,813
313,458
Company pension contributions to defined contribution schemes
10,901
15,058
409,714
328,516
Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
7
Directors' remuneration (continued)
18
Remuneration disclosed above include the following amounts paid to the highest paid director:
2024
2023
£
£
Remuneration for qualifying services
195,142
238,458
Company pension contributions to defined contribution schemes
5,729
15,058
8
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
22,806
9,527
Other interest income
9,149
-
0
Total income
31,955
9,527
9
Interest payable and similar expenses
2024
2023
£
£
Interest on finance leases and hire purchase contracts
15,320
17,051
Other interest
6,158
-
0
21,478
17,051
10
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
396,508
269,334
Adjustments in respect of prior periods
4,903
728
Total current tax
401,411
270,062
Deferred tax
Origination and reversal of timing differences
18,809
(44,477)
Adjustment in respect of prior periods
-
0
15
Total deferred tax
18,809
(44,462)
Total tax charge
420,220
225,600
Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
10
Taxation (continued)
19

The actual charge for the period can be reconciled to the expected charge for the period based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit before taxation
2,072,672
1,282,933
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 22.00%)
518,168
282,245
Tax effect of expenses that are not deductible in determining taxable profit
19,516
1,659
Adjustments in respect of prior years
4,903
728
Effect of change in corporation tax rate
-
0
(5,200)
Group relief
(124,411)
(54,906)
Depreciation on assets not qualifying for tax allowances
2,044
1,089
Rate change in relation to deferred tax
-
0
(15)
Taxation charge for the period
420,220
225,600
11
Dividends
2024
2023
£
£
Interim paid
750,000
600,000
12
Intangible fixed assets
Computer software
Patents & Trademarks
Total
£
£
£
Cost
At 1 October 2023
18,228
6,932
25,160
Additions
-
0
21,748
21,748
At 31 December 2024
18,228
28,680
46,908
Amortisation and impairment
At 1 October 2023
17,721
429
18,150
Amortisation charged for the period
507
9,468
9,975
At 31 December 2024
18,228
9,897
28,125
Carrying amount
At 31 December 2024
-
0
18,783
18,783
At 30 September 2023
507
6,503
7,010
Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
20
13
Tangible fixed assets
Land and buildings leasehold
Plant and machinery
Total
£
£
£
Cost
At 1 October 2023
211,350
3,327,283
3,538,633
Additions
4,380
467,315
471,695
At 31 December 2024
215,730
3,794,598
4,010,328
Depreciation and impairment
At 1 October 2023
181,040
2,330,161
2,511,201
Depreciation charged in the period
9,896
381,930
391,826
At 31 December 2024
190,936
2,712,091
2,903,027
Carrying amount
At 31 December 2024
24,794
1,082,507
1,107,301
At 30 September 2023
30,310
997,122
1,027,432

The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts;

2024
2023
£
£
Plant and machinery
297,190
415,616
14
Stocks
2024
2023
£
£
Raw materials, finished goods and goods for resale
2,189,478
2,505,574
15
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
2,688,085
2,736,349
Corporation tax recoverable
77,945
-
0
Amounts owed by group undertakings
9,123,982
5,879,221
Other debtors
700
700
Prepayments and accrued income
323,754
359,033
12,214,466
8,975,303
Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
21
16
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Obligations under finance leases
18
102,928
118,611
Trade creditors
1,245,011
1,340,299
Amounts owed to group undertakings
6,476,253
4,734,736
Corporation tax
-
0
25,737
Other taxation and social security
559,284
484,325
Other creditors
675
8,005
Accruals and deferred income
691,716
635,444
9,075,867
7,347,157

A debenture has been provided by Wrapex Limited dated 13 July 2021, in favour of Santander UK plc by way of fixed and floating charges over the undertaking and all property and assets of the company.

 

The company has provided security over loan notes issued by its parent company Longacre Landmark Limited by way of a fixed and floating charge over the assets of the group.

17
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Obligations under finance leases
18
90,872
208,132
18
Finance lease obligations
2024
2023
Future minimum lease payments due under finance leases:
£
£
Within one year
102,928
105,825
In two to five years
90,872
220,918
193,800
326,743

Finance lease payments represent rentals payable by group for certain items of plant and machinery. The average lease term is 3 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.

Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
22
19
Deferred taxation

Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Liabilities
Liabilities
2024
2023
Balances:
£
£
ACAs
265,181
241,620
Short term timing differences
(26,061)
(21,309)
239,120
220,311
2024
Movements in the period:
£
Liability at 1 October 2023
220,311
Charge to profit or loss
18,809
Liability at 31 December 2024
239,120

The deferred tax liability set out above relates to accelerated capital allowances and is expected to reverse in future; the timing of which is uncertain.

20
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
56,672
76,813

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

21
Share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
101,000 Ordinary shares of £1 each
101,000
101,000

All Ordinary shares have equal voting and participation rights in the company.

Wrapex Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
23
22
Operating lease commitments
Lessee
2024
2023
£
£
Within one year
229,605
154,512
Between two and five years
864,450
473,744
In over five years
205,139
249,350
1,299,194
877,606
23
Capital commitments

Amounts contracted for but not provided in the financial statements:

2024
2023
£
£
Acquisition of tangible fixed assets
-
23,280
24
Related party transactions
Transactions with related parties

The company is exempt from disclosing transactions with other group companies on the basis that it is wholly owned.

 

At the year end the company was owed amounts totalling £9,123,982 (2023: £5,879,221) from Prowrap Limited, its parent company.

 

At the year end the company owed amounts totalling £6,476,253 (2023: £4,734,736) to Procare UK Limited, a fellow group company.

 

The balances are unsecured and repayable on demand.

25
Ultimate controlling party

The parent company is Prowrap Limited, a company registered in England and Wales.

 

Prowrap Limited prepares group financial statements and copies can be obtained from Unit 6 Lodge Causeway Trading Estate, Lodge Causeway, Fishponds, Bristol, BS16 3JB.

 

The ultimate parent company is Longacre Group Limited.

2024-12-312023-10-01falsefalsefalseCCH SoftwareCCH Accounts Production 2024.301Stewart CantleyStanislaus Schmidt-ChiariJoseph BarryJonathan Crowley029812512023-10-012024-12-3102981251bus:Director22023-10-012024-12-3102981251bus:Director32023-10-012024-12-3102981251bus:Director42023-10-012024-12-3102981251bus:Director12023-10-012024-12-3102981251bus:RegisteredOffice2023-10-012024-12-3102981251bus:Agent12023-10-012024-12-31029812512024-12-31029812512022-10-012023-09-3002981251core:RetainedEarningsAccumulatedLosses2022-10-012023-09-3002981251core:RetainedEarningsAccumulatedLosses2023-10-012024-12-3102981251core:OtherResidualIntangibleAssets2024-12-3102981251core:OtherResidualIntangibleAssets2023-09-3002981251core:ComputerSoftware2024-12-3102981251core:PatentsTrademarksLicencesConcessionsSimilar2024-12-3102981251core:ComputerSoftware2023-09-3002981251core:PatentsTrademarksLicencesConcessionsSimilar2023-09-30029812512023-09-3002981251core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-12-3102981251core:PlantMachinery2024-12-3102981251core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-09-3002981251core:PlantMachinery2023-09-3002981251core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3102981251core:CurrentFinancialInstrumentscore:WithinOneYear2023-09-3002981251core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3102981251core:Non-currentFinancialInstrumentscore:AfterOneYear2023-09-3002981251core:CurrentFinancialInstruments2024-12-3102981251core:CurrentFinancialInstruments2023-09-3002981251core:ShareCapital2024-12-3102981251core:ShareCapital2023-09-3002981251core:RetainedEarningsAccumulatedLosses2024-12-3102981251core:RetainedEarningsAccumulatedLosses2023-09-3002981251core:ShareCapital2022-09-3002981251core:RetainedEarningsAccumulatedLosses2022-09-3002981251core:IntangibleAssetsOtherThanGoodwill2023-10-012024-12-3102981251core:ComputerSoftware2023-10-012024-12-3102981251core:PatentsTrademarksLicencesConcessionsSimilar2023-10-012024-12-3102981251core:LandBuildingscore:LongLeaseholdAssets2023-10-012024-12-3102981251core:PlantMachinery2023-10-012024-12-310298125112023-10-012024-12-310298125112022-10-012023-09-3002981251core:UKTax2023-10-012024-12-3102981251core:UKTax2022-10-012023-09-300298125122023-10-012024-12-310298125122022-10-012023-09-3002981251core:ComputerSoftware2023-09-3002981251core:PatentsTrademarksLicencesConcessionsSimilar2023-09-30029812512023-09-3002981251core:ComputerSoftwarecore:ExternallyAcquiredIntangibleAssets2023-10-012024-12-3102981251core:PatentsTrademarksLicencesConcessionsSimilarcore:ExternallyAcquiredIntangibleAssets2023-10-012024-12-3102981251core:ExternallyAcquiredIntangibleAssets2023-10-012024-12-3102981251core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-09-3002981251core:PlantMachinery2023-09-3002981251core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-10-012024-12-3102981251core:Non-currentFinancialInstruments2024-12-3102981251core:Non-currentFinancialInstruments2023-09-3002981251core:WithinOneYear2024-12-3102981251core:WithinOneYear2023-09-3002981251core:BetweenTwoFiveYears2024-12-3102981251core:BetweenTwoFiveYears2023-09-3002981251core:MoreThanFiveYears2024-12-3102981251core:MoreThanFiveYears2023-09-3002981251bus:PrivateLimitedCompanyLtd2023-10-012024-12-3102981251bus:FRS1022023-10-012024-12-3102981251bus:Audited2023-10-012024-12-3102981251bus:FullAccounts2023-10-012024-12-31xbrli:purexbrli:sharesiso4217:GBP